When optimizing your study practice, it is vital to evaluate every trial phase in context.
Nearly 20 years ago Medidata was built around modernizing data capture and management, which ultimately became Rave. Today, we can confidently say we’re so much more than that.
Yesterday we discussed how researchers are trying to incorporate new biomarker data into studies, which can generate a new set of hurdles for clinical development programs. It's clear that overcoming these challenges starts with integration.